You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments

Article info

Article menu

Download PDFPDF

XML
Research Article
Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments

Authors

  • Shreya Raghavan Department of Materials Science and Engineering 2800 Plymouth Rd, Building 28, Room 3044W 48109 Ann Arbor MI USA PubMed articlesGoogle scholar articles
  • Pooja Mehta Department of Materials Science and Engineering 2800 Plymouth Rd, Building 28, Room 3044W 48109 Ann Arbor MI USA PubMed articlesGoogle scholar articles
  • Yuying Xie Department of Computational Mathematics, Science, and EngineeringMichigan State University 48823 East Lansing MI USA PubMed articlesGoogle scholar articles
  • Yu L. Lei Department of Periodontics and Oral Medicine and Department of Otolaryngology Head and Neck Surgery Ann Arbor USA Rogel Cancer Center, North Campus Research ComplexUniversity of Michigan 2800 Plymouth Rd, Building 28, Room 3044W 48109 Ann Arbor MI USA PubMed articlesGoogle scholar articles
  • Geeta Mehta Department of Materials Science and Engineering 2800 Plymouth Rd, Building 28, Room 3044W 48109 Ann Arbor MI USA Department of Biomedical Engineering 2800 Plymouth Rd, Building 28, Room 3044W 48109 Ann Arbor MI USA Department of Macromolecular Sciences and Engineering 2800 Plymouth Rd, Building 28, Room 3044W 48109 Ann Arbor MI USA Rogel Cancer Center, North Campus Research ComplexUniversity of Michigan 2800 Plymouth Rd, Building 28, Room 3044W 48109 Ann Arbor MI USA PubMed articlesGoogle scholar articles

Citation

Raghavan S, Mehta P, Xie Y, et al
Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments
Journal for ImmunoTherapy of Cancer 2019;7:190. doi: 10.1186/s40425-019-0666-1
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.